Coya Therapeutics Inc. (NASDAQ:COYA) on Tuesday announced results from a study designed to evaluate the effects of COYA 303 ...

ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks.

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to males ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...

Taste receptors are specialized proteins that facilitate the sense of taste. There are different groups of receptors for ...

Receptor proteins, expressed on the cell surface or within the cell, bind to different signaling molecules, known as ligands, ...

Although type 2 diabetes is often regarded as a disease of ageing, cases of type 2 diabetes in children and adolescents have ...

If there's one thing that's crystal clear about Alzheimer's disease, it's this: It eats away at neurons and the links between ...